Prevalência de anemia ferropriva em pacientes com câncer internados no Hospital do Câncer de Dourados, MS

Abstract

The cancer and anemia are recognized as important public health problems and about 50 % of cancer patients have anemia, representing a major cause of morbidity in this population. Anemia may be a common side effect of chemotherapy and radiotherapy, and characterized possibly the most powerful as contributors to physical fatigue and the incidence and severity depend on tumor type, patient age, disease stage, type and intensity of treatment Despite improvements in other symptoms of illness, fatigue remains inadequately discussed and treated. Knowing this, this study evaluated the prevalence of iron deficiency anemia in cancer patients at the Hospital do Cancer de Dourados, MS. A cross-sectional study where they were invited to participate in the study all patients with cancer admitted during the study period was performed. Daily the data (gender, date of birth and hemoglobin) were collected from the patients' medical records and the later were tabulated and analyzed by the Excel. The results showed that of the 48 patients analyzed, mean age 58 years, 42 (87%) had hemoglobin values ​​below the reference These findings indicate a high prevalence of anemia among patients with cancer and suggest the need for further studies to evaluate the factors involved in the development of anemia, Apart from to implementation of specific treatments that optimize assistance with the purpose of to improving the quality of life of patients.